Acutus Medical Inc

Company Profile

Acutus Medical Inc had its IPO on 2020-08-06 under the ticker symbol AFIB.

The company operates in the Healthcare sector and Medical Devices industry. Acutus Medical Inc has a staff strength of 338 employees.

Stock update

Shares of Acutus Medical Inc opened at $0.5 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.49 - $0.5, and closed at $0.49.

This is a +1.24% increase from the previous day's closing price.

A total volume of 150,704 shares were traded at the close of the day’s session.

In the last one week, shares of Acutus Medical Inc have increased by +0.41%.

Acutus Medical Inc's Key Ratios

Acutus Medical Inc has a market cap of $33.86 million, indicating a price to book ratio of 0.3908 and a price to sales ratio of 1.462.

In the last 12-months Acutus Medical Inc’s revenue was $15.76 million with a gross profit of $-15662000 and an EBITDA of $-102651000. The EBITDA ratio measures Acutus Medical Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Acutus Medical Inc’s operating margin was -693.78% while its return on assets stood at -43.81% with a return of equity of -89.82%.

In Q3, Acutus Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 20.8%.

Acutus Medical Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.4 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Acutus Medical Inc’s profitability.

Acutus Medical Inc stock is trading at a EV to sales ratio of 1.0881 and a EV to EBITDA ratio of 0.0654. Its price to sales ratio in the trailing 12-months stood at 1.462.

Acutus Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$114.63 million

Total Liabilities

$18.32 million

Operating Cash Flow

$5.85 million

Capital Expenditure

$755000

Dividend Payout Ratio

0%

Acutus Medical Inc ended 2024 with $114.63 million in total assets and $0 in total liabilities. Its intangible assets were valued at $114.63 million while shareholder equity stood at $57.78 million.

Acutus Medical Inc ended 2024 with $0 in deferred long-term liabilities, $18.32 million in other current liabilities, 28000.00 in common stock, $-533422000.00 in retained earnings and $0.00 in goodwill. Its cash balance stood at $28.00 million and cash and short-term investments were $66.30 million. The company’s total short-term debt was $392,000 while long-term debt stood at $34.31 million.

Acutus Medical Inc’s total current assets stands at $93.89 million while long-term investments were $0.00 and short-term investments were $38.30 million. Its net receivables were $3.21 million compared to accounts payable of $4.64 million and inventory worth $14.60 million.

In 2024, Acutus Medical Inc's operating cash flow was $5.85 million while its capital expenditure stood at $755000.

Comparatively, Acutus Medical Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.49

52-Week High

$2.19

52-Week Low

$0.48

Analyst Target Price

$2.21

Acutus Medical Inc stock is currently trading at $0.49 per share. It touched a 52-week high of $2.19 and a 52-week low of $2.19. Analysts tracking the stock have a 12-month average target price of $2.21.

Its 50-day moving average was $0.65 and 200-day moving average was $0.95 The short ratio stood at 1.76 indicating a short percent outstanding of 0%.

Around 432.4% of the company’s stock are held by insiders while 3822.5% are held by institutions.